5.1 Brevetto
 Distribuzione geografica
Continente #
NA - Nord America 8.017
EU - Europa 7.495
AS - Asia 4.405
SA - Sud America 162
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 36
OC - Oceania 9
Totale 20.186
Nazione #
US - Stati Uniti d'America 7.951
GB - Regno Unito 2.338
CN - Cina 2.113
IT - Italia 1.463
UA - Ucraina 882
SE - Svezia 832
SG - Singapore 783
JP - Giappone 661
TR - Turchia 488
DE - Germania 478
RU - Federazione Russa 288
FI - Finlandia 277
FR - Francia 267
VN - Vietnam 168
IE - Irlanda 163
AT - Austria 130
BR - Brasile 127
BE - Belgio 99
NL - Olanda 88
PL - Polonia 76
EU - Europa 61
KR - Corea 55
IN - India 54
CA - Canada 49
ES - Italia 28
RO - Romania 22
AR - Argentina 18
BD - Bangladesh 17
MX - Messico 13
HK - Hong Kong 12
KE - Kenya 11
LT - Lituania 11
ZA - Sudafrica 11
PT - Portogallo 10
CH - Svizzera 9
AU - Australia 7
ID - Indonesia 7
TG - Togo 7
MA - Marocco 6
PK - Pakistan 6
EC - Ecuador 5
IR - Iran 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
EE - Estonia 4
IL - Israele 4
IQ - Iraq 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
PE - Perù 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SL - Sierra Leone 1
SM - San Marino 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 20.186
Città #
Southend 2.184
Dallas 1.909
Chandler 823
Jacksonville 682
Ann Arbor 650
Ashburn 499
Nanjing 491
Houston 387
Izmir 364
Woodbridge 362
Urbino 333
Singapore 331
Beijing 323
Boardman 175
Nanchang 174
Munich 165
Dublin 150
Wilmington 148
Düsseldorf 136
New York 134
Vienna 128
San Mateo 122
Helsinki 108
Dong Ket 106
Princeton 103
Des Moines 99
Brussels 97
Orciano Di Pesaro 92
Kunming 90
Cambridge 83
Los Angeles 82
Jiaxing 74
Shenyang 69
Tianjin 69
Amsterdam 67
Fairfield 67
Hebei 65
Istanbul 65
Changsha 62
Moscow 60
Velikiy Novgorod 57
Seongnam 52
Kraków 50
Milan 50
Shanghai 43
Santa Clara 41
Hangzhou 39
Bremen 36
Lanzhou 33
Rome 33
Jinan 31
Paris 31
Seattle 29
Venice 28
Ancona 27
Wuppertal 26
Buffalo 25
Council Bluffs 25
Ho Chi Minh City 24
Changchun 23
Toronto 23
Turku 23
San Francisco 22
Warsaw 21
Dearborn 20
Guangzhou 20
Tokyo 19
Civitanova Marche 18
Hanoi 18
West Jordan 18
Stockholm 17
Brooklyn 16
Frankfurt am Main 16
Ningbo 16
Zhengzhou 16
Bologna 15
Florence 15
Atlanta 14
London 14
Redwood City 14
Chicago 13
Denver 13
Montreal 13
Dormagen 12
Manchester 12
Nuremberg 12
Poplar 12
Macerata 11
Taranto 11
Auburn Hills 10
Boston 10
Johannesburg 10
Orange 10
Parma 10
Phoenix 10
Ankara 9
Augusta 9
Haikou 9
Lauterbourg 9
Orem 9
Totale 13.400
Nome #
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 1.253
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 1.247
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs 336
Device and single-molecule analysis method by means of detection of the collisions of a target molecule on functionalized nanopores 302
DEVICE FOR EMULATING ENERGY SOURCES USED TO POWER EMBEDDED SYSTEMS/DEVICES 294
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 274
Pharmaceutical composition of [(3-​hydroxy-​4 -​pyron-​2-​yl) methyl] -​amine derivatives and DNA demethylating agents and their use as anti-​neoplastic drugs 266
Microfluidic-formulated leukosome compositions and fabrication methods therefor 262
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,2-DIAMINE COMPOUND AND OPTICALLY ACTIVE NIOBIUM CATALYST 236
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 235
2,4,5-TRISUBSTITUTED OXAZOLES 232
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 227
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell'aria 226
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 225
Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment 224
Drug delivery systems 223
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 221
Corpo cavo di Sonda geotermica e Sonda geotermica 215
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 214
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 214
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 212
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 209
Attrezzo ginnico sportivo 209
Acyclovir prodrug and its use in pharmaceutical compositions 209
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 207
Processo per la preparazione di esteri degli acidi 2-aril-alcanoici 207
Method And Relative Test Structure For Measuring The Coupling Capacitance Between Two Interconnect Lines 206
Control system of acoustic echo cancellers for telephone terminals with handset or handsfree 205
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 204
Delivery of Contrasting Agents for Magnetic Resonance Imaging 198
Peripherally Restricted FAAH Inhibitors 197
Procedimento perfezionato per la riduzione di composti organici mediante l'impiego di idruro di magnesio 196
Biomimetic proteolipid vesicle compositions and uses thereof 192
Filtro per l’equalizzazione e/o la Linearizzazione sistemi non lineari 190
Procedimento per la preparazione di monosialoganglioside 188
A process for the preparation of monosialoganglioside by autolysis of cattle brain. 187
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 186
Production of triterpenic acids by in vitro culture of calluses deriving from the pulp of red sentinel apples 185
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 184
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell’aria 182
Procedimento per la preparazione di biopolimeri 182
DEVICE FOR GENERATING MICRO- AND NANO-FLOW MOBILE PHASE GRADIENTS FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 180
Procedimento per ottenere una sostanza antiossidante da peci fenoliche. 176
“Tretamerous derivative of indole-3-carbinol with anticancer activity and method of synthesis of said derivative “ 176
AMINOPYRROLE DERIVATIVES 175
Nanoparticles for delivery of a pharmacologically active agent 174
Procedimento per la produzione di esteri metilici di acidi grassi per reazione di trigliceridi di origine naturale con alcol metilico in presenza di resine 173
5-fluorocitosina come agente antibatterico 173
Nutritional supplement, especially for dairy products, comprises leptin. 172
Use of microparticles for antigen delivery 171
DERIVATIVES OF [(3-HYDROXY-4-PYRON-2-YL)-METHYL]-AMINE AND USE THEREOF AS ANTI-NEOPLASTIC DRUGS 170
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 167
5-fluorocitosina come agente antibatterico 167
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 165
Derivati 2-Acilamminoalchilindolici come Antagonisti/Agonisti Parziali della Melatonina 165
Preparation of glutathione derivatives as antiviral agents 163
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 160
PYRROLO[3,4-d]PYRIMIDINES 159
ANTIINFLAMMATORY OXAZOLES 158
A process for obtaining chemically defined and reproducible polydeoxyribonucleotides. 157
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 157
DERIVATI DI [(3-IDROSSI-4-PIRON-2-IL)METIL]-AMINA E LORO USO COME FARMACI ANTI-NEOPLASTICI 154
PYRROLO[3,4-d]PYRIMIDINES 152
“ ,Processo de producao de antioxidante alquilado, obtido a partir de fenois, cresois e preferencialmente do cardanol hidrogenado, 3-pentadecilfenol (3-PDP) aplicavel como aditivo em combustiveis e lubrificantes. “ 151
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 150
3,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(1H)-ONE DERIVATIVES 149
PREPARATION AND TESTING OF N15-ALKYL AND N15,N15-DIALKYL DERIVATIVES OF TEICOPLANIN COMPOUNDS AS BACTERICIDES 148
Derivati 1-Acilamminoalchilindolici come agonisti della melatonina. 146
3-AMINO-4-CARBAMYLPYRROLE DERIVATIVES 145
PREPARATION OF 3-UREIDO-2,4-DIOXOTETRAHYDRO-1,5-BENZODIAZEPINES AS CCK AND GASTRIN ANTAGONISTS 143
PHARMACOLOGICALLY ACTIVE PYRROLODIAZEPINES 143
Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo utili come additivi per lubrificanti e procedimento per la loro preparazione. 143
Nanosfere polimeriche e relativo utilizzo per veicolare oligonucleotidi. 143
PROCEDIMENTO DI SELEZIONE AUTOMATICA DI FOTOGRAFIE DIGITALI DA UN ARCHIVIO PER LA CREAZIONE AUTOMATICA DI UNA SEQUENZA DI FOTO CHE RAPPRESENTA UNA STORIA EMOZIONALE DA STAMPARE E/O CONSERVARE 143
Procedimento per la produzione di derivati t-butilati del cardanolo e del 3-n-pentadecilfenolo 142
Derivato tetramerico dell'indol-3-carbinolo ad attività anticancerogena e metodo di sintesi del derivato stesso 141
PYRROLODIAZEPINES 141
USE OF ISOLATED MATURE ADIPOCYTES IN REGENERATIVE MEDICINE FOR THE RECONSTRUCTION AND REPARATION OF TISSUES 141
Procedimento di valutazione automatica della qualità di foto digitali 141
AMINOPYRROLE DERIVATIVES 140
PYRROLO[3,4-b]PYRIDINES 138
PREPARATION OF 13-DE(ACETAMIDOGLUPYRANOSYL)-34-DEOXYTEICOPLANIN DERIVATIVES AS ANTIBACTERIALS 135
PYRROLODIAZEPINE DERIVATIVES 133
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 132
Nuovo procedimento per la raffinazione dell'olio derivato dai gusci delle noci di anacardio e prodotto ottenuto con tale procedimento. 130
MACCHINA PER ANALISI CHIMICA COMPRENDENTE LA COMBINAZIONE DELLA SPETTROMETRIA DI MASSA A IONIZZAZIONE ELETTRONICA CON LA CROMATOGRAFIA LIQUIDA 129
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 127
PREPARATION OF DE(ACETYLGLUCOSAMINYL)DIDEHYDRODEOXYTEICOPLANIN DERIVATIVES AS ANTIBIOTICS 125
Procedimento per la produzione di antiossidanti solforati da derivati dell'olio del guscio della noce di anacardio. 125
Preparation of 2-trichloroacetoxy-3,4,5,6-tetrachlorobenzoic acid and compositions containing same for treating benign mammalian neoformations. 125
ANTIINFLAMMATORY 4,5-OXAZOLEDICARBOXAMIDES 124
Manufacture of antioxidants for rubbers from phenolic pitch. 122
Derivati del glutatione e loro utilizzi per il trattamento di malattie virali 120
Procedimento per la preparazione di derivati perfluorurati del cardanolo utili come intermedi organici, idrorepellenti, impregnanti, insetticidi, fitofarmaci e precursori di bisfenoli, resine fenoliche o resine fenoliche modificate. 120
null 118
Filter for the equalization and/or linearization of non-Linear systems 114
Preparation and anticancer activity of tetramerous deriv. of indole-3-carbinol. 114
Inhibitors of anandamide transport and their therapeutic use 112
PREPARATION OF 22-DECHLOROTEICOPLANIN AS ANTIBACTERIALS 111
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 108
Totale 19.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.217 0 0 0 0 0 115 57 127 245 202 234 237
2021/20221.190 100 109 146 244 29 8 34 59 88 44 13 316
2022/20232.093 253 177 137 225 152 482 8 173 266 45 123 52
2023/2024625 56 62 29 51 41 152 39 65 3 35 17 75
2024/20251.768 152 64 434 117 49 112 151 108 180 97 193 111
2025/20263.783 390 851 1.565 623 338 16 0 0 0 0 0 0
Totale 20.284